Sequoia China Leads Funding in Chinese language Mind-Pc Interface Startup
Enterprise capital titan Sequoia China led a multimillion-dollar Angel funding spherical for brain-computer interface (BCI) startup Tianfukang Medical Know-how Co. Ltd., signaling surging non-public capital confidence as Chinese language neurotech builders shift from laboratory breakthroughs to industrial human trials.
The funding, which included participation from the Yuanming Neuroscience Fund, marks the second main capital injection in six months for the one-year-old Beijing startup. Tianfukang beforehand secured early-stage backing from Fosun Pharma’s Fuxian Capital Star Enterprise Fund in March 2026. The capital growth comes as China elevated brain-computer interface expertise to a strategic precedence in its 2026 nationwide financial planning, designating neurotech as a key trade of the longer term.
Tianfukang is creating a proprietary closed-loop neuromodulation platform that targets particular peripheral nerve bundles somewhat than broad nerve trunks or basic tissue. By pairing versatile, self-coiling electrodes with devoted BCI processors and adaptive algorithms, the corporate’s lead system decodes motor intent in post-stroke sufferers with upper-limb paralysis and interprets these alerts into focused electrical stimulation to revive high quality finger and hand actions.
In non-human primate trials, Tianfukang’s system efficiently enabled topics to execute complicated grip and extension duties, fulfilling standards beneath customary upper-extremity motor evaluation frameworks. To speed up scientific translation, the startup established a joint laboratory with Beijing Tiantan Hospital, permitting engineering groups to refine algorithms and {hardware} based mostly on direct suggestions from neurosurgical clinicians.
The industrial funding coincides with main scientific milestones throughout Chinese language analysis hospitals. Neurosurgeons on the First Affiliated Hospital of Harbin Medical College in Heilongjiang province efficiently implanted a completely wi-fi, neuron-level invasive BCI system right into a 56-year-old affected person affected by quadriplegia attributable to a extreme cervical spinal wire harm.
Led by Professor Shi Huaizhang, the surgical workforce deployed ultra-thin, micron-level versatile electrodes able to capturing electrophysiological alerts from particular person neurons with out important tissue injury. The totally implanted wi-fi transceiver operates through an inner rechargeable battery, eliminating exterior wiring and permitting the affected person to calibrate hand-movement intent by way of screen-based suggestions as a part of a multi-disciplinary rehabilitation program.
The wi-fi system implanted in Harbin beforehand underwent landmark scientific evaluations, together with an August 2025 deep-brain tumor boundary mapping trial performed with the Chinese language Academy of Sciences Aerospace Data Analysis Institute. In Might 2026, Beijing Tiantan Hospital initiated a multi-center scientific trial evaluating the identical structure for paralyzed spinal wire harm sufferers.
Concurrently, established Chinese language medical system producers are increasing their footprints throughout non-invasive, interventional, and invasive neurotech markets. Medical large Lepu Medical confirmed that its interventional multi-channel BCI product accomplished preclinical animal testing and superior into human investigator-initiated scientific trials, whereas its permitted implantable deep mind stimulator system entered industrial hospital networks throughout a number of provinces.
